News | May 05, 2026
SK Capital sells Noramco assets to Siegfried
Keeps Halo Pharma to drive independent growth
Keeps Halo Pharma to drive independent growth
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
PMDA is regarded among the most stringent regulatory bodies globally
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
